咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Metastatic sarcomatoid renal c... 收藏

Metastatic sarcomatoid renal cell carcinoma to the mandible treated with Sorafenib

Metastatic sarcomatoid renal cell carcinoma to the mandible treated with Sorafenib

作     者:Kazuhiro Murakami Kazuhiko Yamamoto Kumiko Aoki Ikuyo Fukumoto Tsutomu Sugiura Tadaaki Kirita 

作者机构:Department of Oral and Maxillofacial Surgery Nara Medical University Kashihara Japan 

出 版 物:《Open Journal of Stomatology》 (口腔学期刊(英文))

年 卷 期:2012年第2卷第3期

页      面:222-227页

学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主  题:Sarcomatoid Renal Cell Carcinoma Oral Metastatic Lesion Molecular Targeted Therapy Sorafenib 

摘      要:A case of metastatic sarcomatoid renal cell carcinoma to the mandible treated with Sorafenib is reported. A 76-year-old man consulted us for hyposthesia of the right lower lip. Panorama X-ray film showed a ra-diolucent lesion in the right mandibular body. A diagnosis of metastatic tumor to the mandible from the left kidney was made after evaluation by computed tomography and positron emission tomography, which also revealed multiple bone metastases. After radiotherapy for mandibular and thoracic lesions, nephrectomy was performed. Histological diagnosis was sarcomatoid renal cell carcinoma. Interferon therapy was performed but was not effective;therefore, a molecular targeted drug, Sorafenib, was administered. Sorafenib effectively inhibited the growth of oral and other metastatic lesions for 10 months. Quality of life was relatively well maintained with tolerable adverse effects. The patient survived for as long as 2 years after appearance of the first symptom.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分